Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Primary Target | Pathway | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|---|---|
PDXHCI002 | INK-128 | 1.0 | mTORC1/2 | PI3K/mTOR | 0.3512 | -0.04857 |
PDXHCI002 | Everolimus | 10.0 | mTOR1 | PI3K/mTOR | 0.9869 | -0.04768 |
PDXHCI002 | Everolimus | 0.01 | mTOR1 | PI3K/mTOR | 1.1376 | -0.04754 |
PDXHCI002 | Everolimus | 3.1623 | mTOR1 | PI3K/mTOR | 1.0442 | -0.04734 |
PDXHCI002 | Everolimus | 0.0031623 | mTOR1 | PI3K/mTOR | 1.0799 | -0.04679 |
PDXHCI002 | Bleomycin | 0.1 | Radiation | Misc | 0.9239 | -0.04511 |
HCC1500 | Bleomycin | 0.1 | Radiation | Misc | 0.9640 | -0.04452 |
PDXHCI002 | Everolimus | 1.0 | mTOR1 | PI3K/mTOR | 1.0816 | -0.04413 |
HCC1500 | Etoposide | 0.1 | Topo II | Chemotherapy | 0.9982 | -0.04393 |
PDXHCI002 | Everolimus | 0.001 | mTOR1 | PI3K/mTOR | 1.1106 | -0.04384 |
HCC1500 | Topotecan | 0.0010833 | Topo I | Chemotherapy | 0.7407 | -0.04357 |
HCC1500 | Topotecan | 0.01 | Topo I | Chemotherapy | 0.3779 | -0.04351 |
MDA-MB-134-VI | Abemaciclib | 0.31623 | CDK4/6 | Cell cycle | 0.7639 | -0.04308 |
MDA-MB-453 | Cisplatin | 1.0 | Chemo | Chemotherapy | 0.9696 | -0.04139 |
PDXHCI002 | Etoposide | 0.0010833 | Topo II | Chemotherapy | 1.0798 | -0.04076 |
HCC1500 | Bleomycin | 0.01 | Radiation | Misc | 1.0429 | -0.04012 |
PDXHCI002 | Topotecan | 0.1 | Topo I | Chemotherapy | -0.1014 | -0.03893 |
PDXHCI002 | Torin2 | 0.1 | mTOR/ATM/ATR | PI3K/mTOR | 0.4925 | -0.03840 |
CAL-51 | Palbociclib | 1.0 | CDK4/6 | Cell cycle | 0.4516 | -0.03770 |
CAL-51 | Palbociclib | 0.31623 | CDK4/6 | Cell cycle | 0.5284 | -0.03729 |
CAL-51 | Palbociclib | 0.1 | CDK4/6 | Cell cycle | 0.6466 | -0.03669 |
PDXHCI002 | Torin2 | 0.0031623 | mTOR/ATM/ATR | PI3K/mTOR | 1.3716 | -0.03537 |
PDXHCI002 | INK-128 | 0.0031623 | mTORC1/2 | PI3K/mTOR | 1.4120 | -0.03534 |
PDXHCI002 | Ipatasertib | 10.0 | AKT | PI3K/mTOR | 1.0989 | -0.03489 |
CAL-51 | Abemaciclib | 0.031623 | CDK4/6 | Cell cycle | 0.5674 | -0.03450 |